Boston Scientific (BSX) Current Deferred Tax Assets (2016 - 2019)
Boston Scientific's Current Deferred Tax Assets history spans 11 years, with the latest figure at $4.2 billion for Q4 2019.
- For Q4 2019, Current Deferred Tax Assets rose 4722.99% year-over-year to $4.2 billion; the TTM value through Dec 2019 reached $4.2 billion, up 4722.99%, while the annual FY2019 figure was $4.2 billion, 4722.99% up from the prior year.
- Current Deferred Tax Assets for Q4 2019 was $4.2 billion at Boston Scientific, up from $189.0 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $4.2 billion in Q4 2019 and bottomed at $43.0 million in Q3 2018.
- The 5-year median for Current Deferred Tax Assets is $85.5 million (2016), against an average of $383.8 million.
- The largest annual shift saw Current Deferred Tax Assets plummeted 84.88% in 2016 before it skyrocketed 4722.99% in 2019.
- A 5-year view of Current Deferred Tax Assets shows it stood at $496.0 million in 2015, then tumbled by 84.88% to $75.0 million in 2016, then decreased by 12.0% to $66.0 million in 2017, then surged by 31.82% to $87.0 million in 2018, then surged by 4722.99% to $4.2 billion in 2019.
- Per Business Quant, the three most recent readings for BSX's Current Deferred Tax Assets are $4.2 billion (Q4 2019), $189.0 million (Q3 2019), and $175.0 million (Q2 2019).